companies in the health sector evaluated in detail per year.
investments in companies that are evolving the health experience.
in equity invested in companies since our first fund.
years of technical, executive and entrepreneurial experience in health.
Green Rock is an independent Venture Capital and Private Equity firm. We invest in high potential companies that have a positive impact on health.
Seed, Series A and Early Private Equity
We make the majority of our investments in the initial stages of the company. We know the responsibility of being one of a company's first institutional partners and the impact this has on its future success. So we go beyond financial capital to collaborate with founders on their key mentoring and connection needs.
Operating independently
We are close to the business groups that define health in Brazil, such as networks of hospitals, clinics, laboratories, insurance companies, industry and biotechnology, but we do not have a corporate association with any of them. This guarantees us the necessary autonomy for an impartial and confidential analysis, and allows entrepreneurs to extract the maximum potential from their business without limiting it to an agreement with strategic managers.
Specialized in health
Our team and committees are made up of doctors, executives and entrepreneurs who have lived health every day for years. We have in-depth knowledge of the market structure, its regulations, business models, dynamics and trends. More than that, our passion for the topic allows us to discuss solutions with technical and ethical depth, and our reputation allows us to identify and access better investment opportunities in health.
Seeking capital to move
health? Get in touch
We partner with winning teams along their entrepreneurial journey to evolve health
The future of the sector depends on innovation and entrepreneurship
At the same time that we are a reference in research and management, Brazil faces serious challenges in health care. On the one hand, we are experiencing a supplementary health crisis that requires new business models. On the other hand, a latent and growing demand from the population, whose number of chronic diseases and risk factors increases, without an adequate distribution of health services. With some local peculiarities, the same scenario extends throughout Latin America.
For this reason, the health sector cannot rely solely on its incumbents. We want to help form the next generation of companies that will improve system efficiency, encourage disease prevention and control, expand access to services, and advance the frontiers of current medicine.